Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Operating activities:
Net loss	$ (6,176,416)	$ (8,661,792)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	181,332	295,178
Noncash lease expense	171,718	213,539
Stock option expense	190,380	2,687,529
Issuance of common stock for services	135,870
Restricted stock compensation	176,775	71,916
Bad debt expense	109,302
Loss on disposition of asset	41,108	12,618
Loss from investment in unconsolidated affiliate	5,350	4,215
Change in operating assets and liabilities:
Accounts receivable	19,441	(18,752)
Inventories	(331,305)	(99,452)
Prepaid expenses and other current assets	264,481	(49,464)
Other assets	(5,768)	(6,926)
Accounts payable, accrued expenses and other current liability	378,046	(93,223)
Deferred income	28,934	162,495
Lease liability – operating lease	(195,366)	(210,194)
Other non-current liabilities	(19,261)	15,015
Net cash used in operating activities	(5,025,379)	(5,677,298)
Investing activities:
Purchase of equipment	(34,875)	(214,524)
Acquisition of Dripkit		(413,069)
Net cash used in investing activities	(34,875)	(627,593)
Financing activities:
Proceeds from issuance of common stock, exercise of options		12,600
Repayment of loans	(5,932)	(41,671)
Repayment of finance lease	(21,729)	(18,094)
Proceeds from issuance of common stock, ATM offering, net of issuance cost		95,256
Proceeds from issuance of common stock, exercise of warrants, net of issuance costs		1,702,596
Proceeds from issuance of equity securities, exempt offering, net of issuance costs		1,649,736
Cash paid for offering costs		(368,783)
Net cash provided by (used in) financing activities	(27,661)	3,031,640
Effect of foreign exchange on cash	53,287	(19,604)
Net change in cash	(5,034,628)	(3,292,855)
Cash, beginning of period	8,315,053	10,815,954
Cash, end of period	3,280,425	7,523,099
Supplemental disclosure of cash flow information:
Cash paid for interest	3,760	7,077
Cash paid for taxes		800
Non-cash transactions:
ROU assets and liabilities added during the period		558,371
Common stock issued in acquisition of Dripkit		426,844
Forgiveness of stock issuance costs	40,000
Stock issuance costs accrued		$ 273,762